Therefore, the aim of this study is to examine the associations of PD1 and TIM3 gene polymorphisms with the overall survival (OS) of patients in a prospective cohort of patients with HBV-related HCC receiving various treatments. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.